| Active substance |
Ipamorelin |
| Also known as |
N/A |
| Blood pressure |
No significant impact |
| Category |
Peptides |
| Chemical name |
Ipamorelin |
| Dosage |
2 Mg |
| Dosage (medical) |
Typically, 200-300 mcg three times a day |
| Dosage (sports) |
200-300 mcg two to three times a day |
| Dosage Unit |
Ml |
| ean13 |
1391907071354 |
| Effects |
Increased lean muscle mass, reduced body fat, improved recovery |
| FORM |
Injection |
| Formula |
C38H49N9O5 |
| Half-life |
Approximately 2 hours |
| Hepatotoxicity |
None reported |
| Lab Test |
Growth hormone levels can be monitored |
| Main action |
Stimulates the release of growth hormone |
| Milliliter Size |
10 Ml |
| Reference |
AX013 |
| Side effects |
Headaches, light-headedness, soreness at injection site |
| Storage conditions |
Store in a cool, dry place away from light |
| Substance class |
Growth hormone secretagogue |
| Trade name |
Not marketed under a specific trade name |
| Use in sports |
Commonly used for muscle building and performance enhancement |
| Water Retention |
Minimal |
| Packing |
Vial |
